// App-Quantinova.ai

2889 : A Three-Gene Immune Signature Including IDO1, BIN1 and PLXNC1 Predicts Survival in Acute Myeloid Leukemia

Researchers

Presenter

  • Simone Ragaini

Principal Investigators

  • Giovanni Marconi

  • Sarah Parisi

  • Chiara Sartor

  • Jacopo Nanni

  • Gianluca Cristiano

  • Annalisa Talami

  • Matteo Olivi

  • Darina Ocadlikova

  • Marilena Ciciarello

  • Giulia Corradi

  • Emanuela Ottaviani

  • Cristina Papayannidis

  • Stefania Paolini

  • Jayakumar Vadakekolathu

  • Michele Cavo

  • Sergio Rutella

  • Antonio Curti

Medical Centers

  • "Seragnoli" Institute of Hematology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy

  • John van Geest Cancer Research Centre,Nottingham Trent University,Nottingham,United Kingdom

  • Istituto di Ematologia e Oncologia Medica "Lorenzo e Ariosto Seràgnoli" Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy

  • Institute of Hematology "L. e A. Seràgnoli", Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria S. Orsola-Malpighi, Bologna, Italy

  • Institute of Hematology "L. and A. Seràgnoli", Department of Experimental, Diagnostic and Specialty Medicine, Università di Bologna - UNIBO, Bologna, Italy

  • Centre for Health, Ageing and Understanding Disease (CHAUD), Nottingham Trent University, Nottingham, United Kingdom

  • Azienda Ospedaliero-Universitaria S. Orsola-Malpighi, Bologna, Italy

Locations

  • Italy

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • Bridging Integrator 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved